サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356660

勃起不全デバイス市場レポート：2030年までの動向、予測、競合分析

Erectile Dysfunction Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

勃起不全デバイス市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

勃起不全デバイスの動向と予測

世界の勃起不全装置市場は、2024年から2030年までのCAGRが8.3%で、2030年までに推定29億米ドルに達すると予想されています。この市場の主な促進要因は、前立腺がんの有病率の増加、ユーザーフレンドリーなED機器に対する需要の高まり、慢性疾患や加齢による勃起不全の症例の増加です。世界の勃起不全治療器市場は、病院・ASC市場や診療所市場にビジネスチャンスがあり、将来性が期待されます。

勃起不全機器市場の洞察

Lucintelの予測では、加齢に関連する前立腺がんやCVDに罹患しているこの年齢層の患者の間で勃起不全デバイスの需要が高まっているため、60歳以上が予測期間中に最も高い成長を遂げる見込みです。

ヘルスケアは、前立腺がんや勃起不全を患う患者を治療するために、医療専門家による勃起不全治療器の需要が増加しているため、最大のセグメントであり続けると思われます。

北米は、ハイテク機器が入手しやすく、ヘルスケアシステムが確立されているため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の勃起不全デバイス市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の勃起不全デバイス市場動向（2018-2023）と予測（2024-2030）
  • 年齢層別の世界の勃起不全デバイス市場
    • 40年未満
    • 40～60歳
    • 60年以上
  • 製品タイプ別の世界の勃起不全デバイス市場
    • 真空狭窄装置
    • 陰茎インプラント
    • 衝撃波療法
    • その他
  • 原因別の世界の勃起不全デバイス市場
    • 血管障害と糖尿病
    • 神経学的障害
    • その他
  • 最終用途別の世界の勃起不全デバイス市場
    • 病院とASC
    • クリニック

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の勃起不全デバイス市場
  • 北米の勃起不全デバイス市場
  • 欧州の勃起不全デバイス市場
  • アジア太平洋勃起不全デバイス市場
  • その他地域勃起不全デバイス市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 年齢層別の世界の勃起不全デバイス市場の成長機会
    • 製品タイプ別の世界の勃起不全デバイス市場の成長機会
    • 原因別の世界の勃起不全デバイス市場の成長機会
    • 最終用途別の世界の勃起不全デバイス市場の成長機会
    • 地域別の世界の勃起不全デバイス市場の成長機会
  • 世界の勃起不全デバイス市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の勃起不全デバイス市場の能力拡大
    • 世界の勃起不全デバイス市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Boston Scientific
  • Rigicon
  • Coloplast
  • Promedon
  • Sanofi
  • Bayer
  • Zephyr Surgical Implants
目次

Erectile Dysfunction Device Trends and Forecast

The future of the global erectile dysfunction device market looks promising with opportunities in the hospital & ASC and clinic markets. The global erectile dysfunction device market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are increasing prevalence of prostate cancer, growing demand for user friendly ED devices, and rising cases of erectile dysfunctional caused by chronic disease or aging.

A more than 150-page report is developed to help in your business decisions.

Erectile Dysfunction Device by Segment

The study includes a forecast for the global erectile dysfunction device by age group, product type, cause, end use, and region.

Erectile Dysfunction Device Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Less than 40 Years
  • 40-60 Years
  • More than 60 Years

Erectile Dysfunction Device Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Vacuum Constriction Devices
  • Penile Implants
  • Shockwave Therapy
  • Others

Erectile Dysfunction Device Market by Cause [Shipment Analysis by Value from 2018 to 2030]:

  • Vascular Disorders and Diabetes
  • Neurological Disorders
  • Others

Erectile Dysfunction Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and ASCs
  • Clinics

Erectile Dysfunction Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Erectile Dysfunction Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies erectile dysfunction device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the erectile dysfunction device companies profiled in this report include-

  • Boston Scientific
  • Rigicon
  • Coloplast
  • Promedon
  • Sanofi
  • Bayer
  • Zephyr Surgical Implants

Erectile Dysfunction Device Market Insights

Lucintel forecasts that more than 60 years is expected to witness highest growth over the forecast period due to growing demand for erectile dysfunction devices among patients of this age range suffering from age-related prostate cancer and CVDs.

Clinic will remain the largest segment due to growing demand for erectile dysfunction devices in this setting by healthcare professionals to treat individuals suffering from prostate cancer or erectile dysfunction issues.

North America is expected to witness highest growth over the forecast period due to significant availibility of high-tech devices and presence of well established healthcare system in this region.

Features of the Global Erectile Dysfunction Device Market

Market Size Estimates: Erectile dysfunction device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Erectile dysfunction device market by various segments, such as by age group, product type, cause, end use and region in terms of($B).

Regional Analysis: Erectile dysfunction device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different age groups, product types, causes, end uses, and region.s for the erectile dysfunction device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the erectile dysfunction device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the erectile dysfunction device market size?

Answer: The global erectile dysfunction device market is expected to reach an estimated $2.9 billion by 2030.

Q.2. What is the growth forecast for erectile dysfunction device market?

Answer: The global erectile dysfunction device market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the erectile dysfunction device market?

Answer: The major drivers for this market are increasing prevalence of prostate cancer, growing demand for user friendly ED devices, and rising cases of erectile dysfunctional caused by chronic disease or aging.

Q.4. What are the major segments for erectile dysfunction device market?

Answer: The future of the erectile dysfunction device market looks promising with opportunities in the hospital & ASC and clinic markets.

Q.5. Who are the key erectile dysfunction device market companies?

Answer: Some of the key erectile dysfunction device companies are as follows:

  • Boston Scientific
  • Rigicon
  • Coloplast
  • Promedon
  • Sanofi
  • Bayer
  • Zephyr Surgical Implants

Q.6. Which erectile dysfunction device market segment will be the largest in future?

Answer: Lucintel forecasts that more than 60 years is expected to witness highest growth over the forecast period due to growing demand for erectile dysfunction devices among patients of this age range suffering from age-related prostate cancer and CVDs.

Q.7. In erectile dysfunction device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to significant availibility of high-tech devices and presence of well established healthcare system in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the erectile dysfunction device market by age group (less than 40 years, 40-60 years, and more than 60 years), product type (vacuum constriction devices, penile implants, shockwave therapy, and others), cause (vascular disorders and diabetes, neurological disorders, and others), end use (hospitals and ASCs and clinics), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Erectile Dysfunction Device Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Erectile Dysfunction Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Erectile Dysfunction Device Market by Age Group
    • 3.3.1: Less than 40 Years
    • 3.3.2: 40-60 Years
    • 3.3.3: More than 60 Years
  • 3.4: Global Erectile Dysfunction Device Market by Product Type
    • 3.4.1: Vacuum Constriction Devices
    • 3.4.2: Penile Implants
    • 3.4.3: Shockwave Therapy
    • 3.4.4: Others
  • 3.5: Global Erectile Dysfunction Device Market by Cause
    • 3.5.1: Vascular Disorders and Diabetes
    • 3.5.2: Neurological Disorders
    • 3.5.3: Others
  • 3.6: Global Erectile Dysfunction Device Market by End Use
    • 3.6.1: Hospitals and ASCs
    • 3.6.2: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Erectile Dysfunction Device Market by Region
  • 4.2: North American Erectile Dysfunction Device Market
    • 4.2.2: North American Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics
  • 4.3: European Erectile Dysfunction Device Market
    • 4.3.1: European Erectile Dysfunction Device Market by Age Group: Less Than 40 Years, 40-60 Years, and More than 60 Years
    • 4.3.2: European Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics
  • 4.4: APAC Erectile Dysfunction Device Market
    • 4.4.1: APAC Erectile Dysfunction Device Market by Age Group: Less Than 40 Years, 40-60 Years, and More than 60 Years
    • 4.4.2: APAC Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics
  • 4.5: ROW Erectile Dysfunction Device Market
    • 4.5.1: ROW Erectile Dysfunction Device Market by Age Group: Less Than 40 Years, 40-60 Years, and More than 60 Years
    • 4.5.2: ROW Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Erectile Dysfunction Device Market by Age Group
    • 6.1.2: Growth Opportunities for the Global Erectile Dysfunction Device Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Erectile Dysfunction Device Market by Cause
    • 6.1.4: Growth Opportunities for the Global Erectile Dysfunction Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Erectile Dysfunction Device Market by Region
  • 6.2: Emerging Trends in the Global Erectile Dysfunction Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Erectile Dysfunction Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Erectile Dysfunction Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Scientific
  • 7.2: Rigicon
  • 7.3: Coloplast
  • 7.4: Promedon
  • 7.5: Sanofi
  • 7.6: Bayer
  • 7.7: Zephyr Surgical Implants